BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-19

  1. 1,485 Posts.
    lightbulb Created with Sketch. 41
    not being negative at all but to me submission will not have significant effect on the price. APPROVAL is what will excite many holders.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.